RE:RE:RE:RE:RE:RE:41 cents Pretty clear that they are stalling.
Big volume sales have obviously been harder to come by post Covid, as businesses are tightening their belts and are hesitant to commit to big money, long term contracts.
Which is ironic, since the US has gone for a dump as far as violence stats are concerned.
The world needs more Pat. The question is does Pat have the sales team and the right marketing game plan to tap into this unbelievably lucrative market?
Time will tell.
Anyone dumb enough to dump now deserves to have their noses rubbed in it later. I personally believe Pat has bottomed out. Low forties (Cdn) is a basement SP, reserved for the like of fly by night snake oil like PRT and Liberty. Evolv continues its swan dive as well.
If I didn't know any better, and I believed in conspiracy theories, I'd almost think the gun lobby and medical supply companies are trying to smother the AI security industry in its crib...safety is bad for business.
Anyone with cash and the cojones to spend it could do worse than putting it in Pat right now. Evans has said there have been multiple sales and more are coming. Pipeline is full, allegedly.
Pretty simple really. First few months of 2022 will either corroborate his statements, or Peter Evans will be the next ex-CEO of Patriot One. The shareholders will revolt with the next set of financials if they are Cronin-esque.
All IMDO.